Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ZYME
ZYME
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ZYME News
Zymeworks Showcases Next-Generation ADC Programs at AACR 2026
3d ago
Newsfilter
Zymeworks to Report Q1 2026 Financial Results on May 7
4d ago
Newsfilter
Zymeworks Appoints New Heads of R&D and Business
Apr 09 2026
Newsfilter
Zymeworks Appoints Kristin Stafford as CFO Effective April 2026
Apr 01 2026
seekingalpha
Zymeworks Appoints New CFO, Stock Rises
Apr 01 2026
NASDAQ.COM
Zymeworks Appoints Kristin Stafford as CFO
Apr 01 2026
Newsfilter
Zymeworks' Investigational Drug ZW191 Receives FDA Fast Track Designation
Mar 30 2026
NASDAQ.COM
Zymeworks Receives FDA Fast Track Designation for ZW191
Mar 30 2026
NASDAQ.COM
ZW191 Receives FDA Fast Track Designation for Ovarian Cancer Treatment
Mar 30 2026
Newsfilter
BETA Technologies Reports Disappointing Q4 Results
Mar 09 2026
Benzinga
Lisata Therapeutics to be Taken Private by Kuva Labs
Mar 09 2026
Benzinga
Zymeworks (ZYME.US) Insider Plans to Sell $6.13 Million Worth of Common Stock via Form 144
Mar 07 2026
moomoo
Zymeworks Q4 2025 Earnings Call Highlights
Mar 03 2026
seekingalpha
Zymeworks Reports 2025 Financials and $250 Million Financing Agreement
Mar 02 2026
NASDAQ.COM
Zymeworks Secures $250 Million Royalty Financing from Royalty Pharma
Mar 02 2026
NASDAQ.COM
Zymeworks Reports Expanded Losses in Q4
Mar 02 2026
NASDAQ.COM
Show More News
